A multicentre, randomised, open-label study comparing the efficacy & safety of once daily (O.D) ORG31540/SR90107a versus adjusted dose intravenous (I.V) unfractioned heparin (UFH) In the initial treat

  • Narayan, Kam, (Primary Chief Investigator (PCI))
  • Leyden, Michael, (Chief Investigator (CI))
  • Rosengarten, Andrew, (Chief Investigator (CI))

Project: Research

StatusFinished
Effective start/end date1/11/0130/04/02